This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants (CFDA 93.242) program, provides $1,188,296 to Brown University to develop and refine a multicomponent behavioral intervention to address both HIV viral suppression and postpartum weight retention among postpartum women living with HIV in South Africa. The 3-year project, starting on September 15, 2024, aims to: 1) refine the planned intervention through participatory...
This $233,335 National Institute of Mental Health project grant supports the adaptation and optimization of the Friendship Bench mental health intervention for adolescent girls and young women in South African HIV pre-exposure prophylaxis (PrEP) delivery settings. The University of Washington will receive funding to support Dr. Jennifer Velloza's development as an independent researcher focused on improving mental health intervention delivery integrated with HIV prevention services for young...
This $715,041 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research to understand real-world choices, preferences, and outcomes related to the roll-out of oral and long-acting injectable PrEP (pre-exposure prophylaxis) among women in Malawi. The study, titled "Better Info on Women's PrEP Choices and Outcomes in Malawi", has three specific aims: 1) Evaluate longitudinal patterns of oral...
This Project Grant award of $197,035 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a 5-year study to design and evaluate a community-based intervention to engage men who use alcohol and substances in HIV prevention services in rural South Africa. The primary objectives are to: 1) explore perceptions and preferences for HIV prevention services among men who frequent local bars (shebeens), 2) develop an intervention...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $180,946 to develop and evaluate a stepped implementation approach for delivering problem-solving therapy to people living with HIV in South Africa. The key products and services to be delivered include: Determining stakeholder preferences for implementing problem-solving therapy through qualitative research with people living with HIV and HIV/mental...
The National Institute of Mental Health (NIMH) awarded a $780,447 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Brigham & Women's Hospital Inc. to test a differentiated service delivery model called CARES-DSD to improve engagement and viral suppression among people with HIV who have experienced treatment interruptions in South Africa. The 5-year project will recruit 300 participants from an ongoing study and evaluate the effectiveness of the CARES-DSD intervention compared...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a cluster randomized controlled trial to test the impact of a long-term, dynamic choice intervention on 12-month viral suppression among HIV clients experiencing treatment interruption in Malawi. The $653,677 award will be used to implement this research initiative over a project period from April 1, 2025 to January 31, 2030. The goal is to...
This $198,531 Project Grant awarded by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) aims to develop and pilot test an integrated intervention that addresses mental health and HIV medication adherence among men who have sex with men (MSM) in South Africa. The proposed "WECARE" intervention will be based on principles of problem-solving therapy, minority stress theory, and a status-neutral approach to target both mental...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to adapt and evaluate the effectiveness of the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention to increase pre-exposure prophylaxis (PrEP) continuation and adherence among adolescent girls and young women in South Africa and Zimbabwe. The total funding amount is $710,187, with an award date of September 11, 2024 and an...
ENHANCED PROBLEM-SOLVING THERAPY AND HIV ENGAGEMENT SUPPORT TO IMPROVE PERINATAL MENTAL HEALTH AND HIV OUTCOMES IN MALAWI: A RANDOMIZED CONTROLLED TRIAL - ABSTRACT IN SUB-SAHARAN AFRICA, UNIVERSAL ACCESS TO ANTIRETROVIRAL THERAPY (ART) FOR PREGNANT AND BREASTFEEDING PERSONS, KNOWN AS OPTION B+, HAS RAPIDLY EXPANDED ART ACCESS IN LOW AND MIDDLE-INCOME COUNTRIES, YIELDING DECLINES IN VERTICAL HIV TRANSMISSION AND IMPROVEMENTS IN VIRAL SUPPRESSION. HOWEVER, DISENGAGEMENT FROM PERINATAL HIV CARE IN THE PERINATAL PERIOD HAS EMERGED AS A MAJOR CHALLENGE TO SUSTAINING THE SUCCESS OF OPTION B+. INTERVENTIONS TO SUPPORT SUSTAINED ENGAGEMENT IN PERINATAL HIV CARE ARE URGENTLY NEEDED. PERINATAL DEPRESSION (PND) IS COMMON AMONG WLHIV AND IS AN IMPORTANT BARRIER TO HIV CARE ENGAGEMENT. PND IS DEFINED AS ONSET OF DEPRESSION IN PREGNANCY AND/OR WITHIN THE FIRST 3-6 MONTHS POSTPARTUM. AMONG WLHIV IN SUB-SAHARAN AFRICA, 30-40% EXPERIENCE PRENATAL DEPRESSION AND 20%-30% EXPERIENCE POSTNATAL DEPRESSION. PND IN WLHIV HAS BEEN LINKED TO INCREASED HIV VIRAL LOAD, POSTPARTUM DISENGAGEMENT FROM HIV CARE, AND REDUCED INFANT HIV TESTING, MAKING PND AN IMPORTANT BARRIER TO REACHING UNAIDS 2025 GOALS AND ENDING THE HIV EPIDEMIC. TO ADDRESS THESE GAPS, NIMH (NOT-MH-21-270) HAS PRIORITIZED TESTING INTERVENTIONS TO ADDRESS PND AMONG WLHIV IN THE PERINATAL PERIOD, INCLUDING THEIR IMPACT ON HIV-RELATED OUTCOMES AMONG THE MOTHERS AND THEIR INFANTS. HOWEVER, FEW EVIDENCE-BASED INTERVENTIONS EXIST THAT ADDRESS BOTH PERINATAL MENTAL HEALTH AND HIV CARE OUTCOMES FOR WLHIV, AND EVEN FEWER ARE POSITIONED FOR RAPID TRANSLATION INTO PRACTICE THROUGH INCORPORATION OF A RIGOROUS IMPLEMENTATION SCIENCE FRAMEWORK AT THE EFFECTIVENESS TRIAL STAGE. FUNDED BY NIMH (R34MH116806), OUR TEAM ENHANCED THE FRIENDSHIP BENCH, AN EVIDENCE-BASED COUNSELING INTERVENTION, TO ADDRESS PND AND HIV CARE ENGAGEMENT FOR WLHIV. IN A PILOT INDIVIDUALLY RANDOMIZED CONTROLLED TRIAL, THE ENHANCED FRIENDSHIP BENCH DEMONSTRATED HIGH LEVELS OF ACCEPTABILITY, FEASIBILITY, AND FIDELITY TO THE INTERVENTION PROTOCOL, AS WELL AS PRELIMINARY EFFICACY TO IMPROVE BOTH PND AND ENGAGEMENT IN HIV CARE FOR WLHIV IN MALAWI. BUILDING ON THIS WORK, THE OBJECTIVE OF THIS PROPOSAL IS TO EVALUATE THE EFFICACY OF THE ENHANCED FRIENDSHIP BENCH, COMPARED TO USUAL CARE, IN A FULLY POWERED RANDOMIZED CONTROLLED TRIAL TO IMPROVE PND, HIV CARE ENGAGEMENT, AND SECONDARY INFANT HEALTH OUTCOMES THROUGH 12 MONTHS POSTPARTUM; TEST HYPOTHESIZED MEDIATORS AND MODERATORS THAT WILL HELP ELUCIDATE MECHANISMS OF INTERVENTION ACTION; AND COLLECT KEY IMPLEMENTATION SCIENCE METRICS IN A HYBRID TYPE I DESIGN TO ACCELERATE TRANSLATION OF FINDINGS INTO PRACTICE. OUR TEAM IS EXCEPTIONALLY WELL QUALIFIED TO ADDRESS THESE AIMS GIVEN OUR DEVELOPMENT AND ENHANCEMENT OF THE FRIENDSHIP BENCH FOR PERINATAL WLHIV; OUR EXPERTISE IN HIV, PERINATAL MENTAL HEALTH, AND IMPLEMENTATION SCIENCE; AND OUR LONGSTANDING RESEARCH INFRASTRUCTURE IN MALAWI. COMPLETION OF THE PROPOSED AIMS WILL SHIFT CLINICAL PRACTICE BY PROVIDING A CULTURALLY APPROPRIATE, SCALABLE COUNSELING INTERVENTION THAT IMPROVES PND AND ENGAGEMENT IN HIV CARE OUTCOMES FOR WLHIV THAT IS POISED FOR RAPID TRANSLATION INTO PRACTICE.